This is a guest post by Johan Thyberg, a 1947-born Swedish biologist and a well-known activist against science fraud. His 2009 published book “Scientific Fraud or Legal Scandal?” meticulously narrates several fraud scandals in Swedish science, one of which I referred to when introducing a guest post of another concerned Swedish academic. Until his academic retirement, Thyberg used to be professor for cell and molecular biology at Karolinska Institutet (KI) in Stockholm, the showplace of probably the biggest medicine scandal of recent times, that of the trachea transplant surgeon Paolo Macchiarini. Continue reading “Karolinska in denial, by Johan Thyberg”
A gang of Indian nanotechnology scientists, allegedly from Annamalai University in India, placed in 2014-2015 several papers in different journals, all of them about nanoparticle synthesis using extracts from various local plants. Most papers went into the journal Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, published by Elsevier. The publications were harshly criticised on PubPeer for their poor science, but also for suspected data manipulations (electron microscopy images, photographs of bacteria dishes and X-ray diffraction measurements were reused across different unrelated papers, see PubPeer examples below).
Five nanotechnology papers at Elsevier are now about to be retracted, at least four of them from Spectrochimica Acta Part A. The concerns about research quality and data integrity may have been however less decisive here. The faculties of the Annamalai University carry no mention of any of these authors as their members, all of the provided corresponding email addresses are from Gmail. A publishing scam, possibly including fraudulent peer review, is the likely reason why these papers are being retracted now. Continue reading “The smelly compost heap of plant-based nanoparticles”
Bone marrow stem cells are magic, they can do everything. If you don’t believe it, you are simply a loser scientist and will never get funded.
Prior to his bombastic fall from grace, the celebrity surgeon and professor of regenerative medicine Paolo Macchiarini was considered a genius stem cell wizard and a miracle healer. He not only fully trusted bone marrow cells to generate any kind of tissue inside his patients, nay, he also published his results in highest profile journals like The Lancet (which, by standard academic definition, is proof enough that his theory and methods were valid). Macchiarini did not chase money, neither funding nor salary, it was chasing him. Even after media revealed mass patient deaths and gross inconsistency between Macchiarini’s published reports and the actual medical files of his patients, the Elsevier-run Lancet is reluctant to retract his papers.
Simply put, the faith in the force of the bone marrow stem cells is stronger than their science. These cells are often referred to as mesenchymal stem cells; basically they are those undifferentiated cells from the bone marrow which do not carry the established markers of hematopoietic (blood-generating) stem cells. What these “mesenchymal stem cells” are actually a mixture of, and which types of cells or tissues they are really able to differentiate into, is still a subject of an ongoing research. Unless you are a stem cell believer, that is, then you don’t bother with such details. Continue reading “The stem cell faith healers, or magic inside your bone marrow”
A large body of scientific nanotechnology literature is dedicated to the biomedical aspect of nanoparticle delivery into cells and tissues. The functionalization of the nanoparticle surface is designed to insure their specificity at targeting only a certain type of cells, such as cancers cells. Other technological approaches aim at the cargo design, in order to ensure the targeted release of various biologically active agents: small pharmacological substances, peptides or entire enzymes, or nucleotides such as regulatory small RNAs or even genes. There is however a main limitation to this approach: though cells do readily take up nanoparticles through specific membrane-bound receptor interaction (endocytosis) or randomly (pinocytosis), these nanoparticles hardly ever truly reach the inside of the cell, namely its nucleocytoplasmic space. Solid nanoparticles are namely continuously surrounded by the very same membrane barrier they first interacted with when entering the cell. These outer-cell membrane compartments mature into endosomal and then lysosomal vesicles, where their cargo is subjected to low pH and enzymatic digestion. The nanoparticles, though seemingly inside the cell, remain actually outside. How so? Continue reading “Do nanoparticles deliver? Merck’s Smart Flares and other controversies”